Pronounced clinical response following the oncolytic vaccinia virus GL-ONC1 and chemotherapy in a heavily pretreated ovarian cancer patient-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pronounced clinical response following the oncolytic vaccinia virus GL-ONC1 and chemotherapy in a heavily pretreated ovarian cancer patient

Published:2019-11 Issue:10 Volume:30 Page:1064-1066
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Mori Kristina M.,Giuliano Peter D.,Lopez Katrina L.,King Monica M.,Bohart Randy,Goldstein Bram H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference8 articles.

1. Cancer statistics, 2018.;Siegel;CA Cancer J Clin,2018

2. Platinum or nonplatinum in recurrent ovarian cancer: that is the question.;Poveda;Future Oncol,2017

3. Phase 1b study of oncolytic vaccinia virus GL-ONC1 in recurrent ovarian cancer (ROC).;Holloway;J Clin Oncol,2018

4. Phase I trial of intravenous oncolytic vaccinia virus (GL-ONC1) with cisplatin and radiotherapy in patients with locoregionally advanced head and neck carcinoma.;Mell;Clin Cancer Res,2017

5. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer. National Cancer Institute of the United States, National Cancer Institute of Canada.;Therasse;J Natl Cancer Inst,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Viruses in Cancer Immunotherapy;Advanced Therapeutics;2024-05-22

2. Recent progress in combination therapy of oncolytic vaccinia virus;Frontiers in Immunology;2024-03-13

3. Research Advances of Clinical Application of Oncolytic Viruses in Treatment of Gynecologic Cancers;Current Cancer Drug Targets;2023-08

4. The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy;Cureus;2023-06-21

5. Recombinant strains of oncolytic vaccinia virus for cancer immunotherapy;Биохимия;2023-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3